Please provide your email address to receive an email when new articles are posted on . Supraventricular arrhythmias may be underestimated in patients who have received percutaneous patent foramen ...

The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia. Landiolol is a selective beta-1 adrenergic ...

Credit: AOP Health. Rapiblyk is supplied as a lyophilized powder containing 280mg of landiolol (equivalent to 300mg of landiolol HCl) in a single-dose vial. It is intended for use in intensive care, ...

Approval was based on the combined results from five studies of adults with supraventricular tachycardia. The FDA has approved AOP Health’s Rapiblyk (landiolol) for the rapid management of atrial ...

Supraventricular arrhythmias are the most widespread group of arrhythmias and affect all age groups. Atrial fibrillation is the most common arrhythmic disorder and is even more prevalent among the ...

Recent studies suggest that cancer patients may be at increased risk for supraventricular tachyarrhythmias (SVTA). We have observed clinically significant SVTA in patients undergoing hematopoietic ...

During atrial fibrillation, the atrioventricular node is bombarded with electrical impulses, which typically result in rapid ventricular rates. The rate at which signals are transmitted to the ...